Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust 4
4 · Kronos Bio, Inc. · Filed Oct 16, 2020
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Transactions
- Conversion
Common Stock
2020-10-14$16.15/sh+185,758$2,999,992→ 4,274,996 total - Conversion
Series A Preferred Stock
2020-10-14−1,565,475→ 0 total→ Common Stock (1,651,576 underlying) - Conversion
Common Stock
2020-10-14+1,651,576→ 4,089,238 total - Conversion
Series Seed Preferred Stock
2020-10-14−300,001→ 0 total→ Common Stock (316,501 underlying) - Conversion
Convertible Promissory Note
2020-10-14→ 0 totalExercise: $16.15Exp: 2022-02-20→ Common Stock (185,758 underlying) - Conversion
Common Stock
2020-10-14+316,501→ 2,437,662 total - Purchase
Common Stock
2020-10-14$19.00/sh+95,500$1,814,500→ 4,370,496 total
Footnotes (2)
- [F1]Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.